Search research articles
Contact Us
Filters
Showing results (21-30 of 101) with videos related to
Page
of 11
Sort By:
Cancer
|
March 13, 2010
Weekly alternating therapy with irinotecan plus cisplatin and etoposide plus cisplatin in the treatment of patients with extensive small cell lung carcinoma
William N William, James Uyeki, Faye M Johnson, et al.
Molecular Cancer Therapeutics
|
June 20, 2023
Discordance of HER2 Expression and/or Amplification on Repeat Testing
Timothy P DiPeri, Kathleen Kong, Kaushik Varadarajan, et al.
Investigational New Drugs
|
September 1, 2021
A phase i study of ixazomib and erlotinib in patients with advanced solid tumors
Shumei Kato, Jacob J Adashek, Vivek Subbiah, et al.
The New England Journal of Medicine
|
March 7, 2003
A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer
Robert S Sandler, Susan Halabi, John A Baron, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 17, 2005
Gene promoter methylation in plasma and sputum increases with lung cancer risk
Steven A Belinsky, Donna M Klinge, Joseph D Dekker, et al.
The Oncologist
|
June 13, 2023
A Phase I Trial of Bevacizumab and Temsirolimus in Combination With Valproic Acid in Advanced Solid Tumors
Blessie Elizabeth Nelson, Apostolia M Tsimberidou, Xueyao Fu, et al.
The Oncologist
|
March 17, 2021
Overview of Ocular Side Effects of Selinexor
Nagham Al-Zubidi, Dan S Gombos, David S Hong, et al.
Journal for Immunotherapy of Cancer
|
October 9, 2024
Phase I/II study of BMS-986156 with ipilimumab or nivolumab with or without stereotactic ablative radiotherapy in patients with advanced solid malignancies
Joe Y Chang, Xinyan Xu, Girish S Shroff, et al.
Investigational New Drugs
|
January 8, 2021
The clinical efficacy and safety of single-agent pembrolizumab in patients with recurrent granulosa cell tumors of the ovary: a case series from a phase II basket trial
Jeffrey A How, Amir Jazaeri, Shannon N Westin, et al.
Journal of Immunotherapy and Precision Oncology
|
June 6, 2022
Corticosteroid-Refractory Myositis After Dual BRAF and MEK Inhibition in a Patient with BRAF V600E-Mutant Metastatic Intrahepatic Cholangiocarcinoma
Timothy P DiPeri, Mehmet Demirhan, Daniel D Karp, et al.
Page
of 11
Search research articles
Search
Showing results (21-30 of 101) with videos related to
Sort By:
Page
of 11
Cancer
|
March 13, 2010
Weekly alternating therapy with irinotecan plus cisplatin and etoposide plus cisplatin in the treatment of patients with extensive small cell lung carcinoma
William N William, James Uyeki, Faye M Johnson, et al.
Molecular Cancer Therapeutics
|
June 20, 2023
Discordance of HER2 Expression and/or Amplification on Repeat Testing
Timothy P DiPeri, Kathleen Kong, Kaushik Varadarajan, et al.
Investigational New Drugs
|
September 1, 2021
A phase i study of ixazomib and erlotinib in patients with advanced solid tumors
Shumei Kato, Jacob J Adashek, Vivek Subbiah, et al.
The New England Journal of Medicine
|
March 7, 2003
A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer
Robert S Sandler, Susan Halabi, John A Baron, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 17, 2005
Gene promoter methylation in plasma and sputum increases with lung cancer risk
Steven A Belinsky, Donna M Klinge, Joseph D Dekker, et al.
The Oncologist
|
June 13, 2023
A Phase I Trial of Bevacizumab and Temsirolimus in Combination With Valproic Acid in Advanced Solid Tumors
Blessie Elizabeth Nelson, Apostolia M Tsimberidou, Xueyao Fu, et al.
The Oncologist
|
March 17, 2021
Overview of Ocular Side Effects of Selinexor
Nagham Al-Zubidi, Dan S Gombos, David S Hong, et al.
Journal for Immunotherapy of Cancer
|
October 9, 2024
Phase I/II study of BMS-986156 with ipilimumab or nivolumab with or without stereotactic ablative radiotherapy in patients with advanced solid malignancies
Joe Y Chang, Xinyan Xu, Girish S Shroff, et al.
Investigational New Drugs
|
January 8, 2021
The clinical efficacy and safety of single-agent pembrolizumab in patients with recurrent granulosa cell tumors of the ovary: a case series from a phase II basket trial
Jeffrey A How, Amir Jazaeri, Shannon N Westin, et al.
Journal of Immunotherapy and Precision Oncology
|
June 6, 2022
Corticosteroid-Refractory Myositis After Dual BRAF and MEK Inhibition in a Patient with BRAF V600E-Mutant Metastatic Intrahepatic Cholangiocarcinoma
Timothy P DiPeri, Mehmet Demirhan, Daniel D Karp, et al.
Page
of 11